The impact of COVID vaccination on incidence of long COVID and healthcare resource utilisation in a primary care cohort in England, 2021–2022
Vaccination against COVID-19 may reduce the risk of long COVID in both immunocompetent and immunocompromised patients. However, no association was found between frequency of primary care visits and vaccination among patients diagnosed in 2021. Future studies with larger sample size, higher vaccine uptake, and longer study periods during the pandemic are needed to further quantify the impact of vaccination on long COVID.
Authors
- Charles Reynard (ORCID: https://orcid.org/0000-0002-7534-2668)
- Kiran K Rai (ORCID: https://orcid.org/0000-0002-3250-0275)
- Theo Tritton
- Jennifer L. Nguyen (ORCID: https://orcid.org/0000-0002-4064-0227)
- Lucy Massey (ORCID: https://orcid.org/0000-0003-0394-2303)
- Leah J. McGrath (ORCID: https://orcid.org/0000-0002-0312-635X)
- Kathleen M. Andersen (ORCID: https://orcid.org/0000-0003-2670-800X)
- Rebecca Butfield (ORCID: https://orcid.org/0009-0005-8521-1863)
- Olivia Massey
- Diana Mendes (ORCID: https://orcid.org/0000-0002-1672-4906)
- Jingyan Yang (ORCID: https://orcid.org/0000-0001-5523-649X)
- Carmen Tsang (ORCID: https://orcid.org/0000-0001-8210-5145)
- Tamuno Alfred
Institutions
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Adelphi Group (United Kingdom) (GB)
- Columbia University (US)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1186/s12879-024-10097-6
- Citations
- 7
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 9.72